SI VI TERAP JUTIKS INK has a total of 19 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Russian Federation. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are SHENZHEN NEPTUNUS PHARMACEUTIC, PHARMACIA CORP and AVENTIS PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Russian Federation | 19 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Biotechnology | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Sugars | |
#5 | Peptides | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Special acyclic compounds | |
#8 | Object sterilising | |
#9 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Zablotski Dzheff | 8 |
#2 | Ehlzein Ehlfatikh | 7 |
#3 | Palle Venkata | 3 |
#4 | Belardinelli Luis | 3 |
#5 | Li Sjaofehn | 2 |
#6 | Belardinelli Luiz | 2 |
#7 | Ibrakhim Prabkha | 2 |
#8 | Tszen Dehvan | 2 |
#9 | Kalla Rao | 2 |
#10 | Vik Majkl M | 2 |
Publication | Filing date | Title |
---|---|---|
RU2442585C2 | Method of diabetes treatment | |
RU2443708C2 | Method of producing a2a-adenosine receptor agonist and polymorphic modifications thereof | |
RU2385322C2 | Method of wound healing with applying antagonists of a2b adenosine receptor | |
RU2346693C2 | Myocardial perfusion imaging using adenosine receptor agonists | |
RU2325161C2 | Use of ranolazine for preparation of medicine for arrhythmia treatment |